Lamotrigin 1 A Pharma

Lamotrigine, the active ingredient in Lamotrigin 1 A Pharma, is an anticonvulsant presented as an oral tablet for oral use. It is used to control seizures in epilepsy, stabilize mood in bipolar disorder, and prevent migraine attacks in appropriate patients, including adults and children as appropriate.

GNH USA supplies Lamotrigin 1 A Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Lamotrigine is employed in several neurological and psychiatric conditions where abnormal neuronal excitability is a key factor.

- Epilepsy: Reduces frequency and severity of seizures. - Bipolar disorder: Helps maintain mood stability and prevent depressive or manic episodes. - Migraine prophylaxis: Decreases the number of migraine attacks and associated disability.

Lamotrigine may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Dizziness - Headache - Rash

Serious or Rare Side Effects: - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Aseptic meningitis - Severe blood dyscrasias (e.g., agranulocytosis)

When prescribing lamotrigine, clinicians should consider several safety measures to minimize risks. - Initiate therapy at low dose: Start with a minimal dose and increase gradually to reduce rash risk. - Monitor skin reactions: Discontinue immediately if a widespread rash or signs of severe cutaneous reaction appear. - Assess hepatic and renal function: Adjust dosing in patients with significant liver or kidney impairment. - Review concomitant medications: Certain drugs can alter lamotrigine levels, requiring dose adjustments. - Pregnancy considerations: Use only if benefits outweigh potential risks, and discuss with obstetric specialist. - Store at room temperature: Keep below 25°C in the original packaging, protected from moisture and light.

Lamotrigine’s plasma concentrations can be affected by several co‑administered medicines, necessitating careful monitoring.

Major Interactions (Avoid): - Valproic acid: Increases lamotrigine levels markedly; may require dose reduction. - Carbamazepine, phenytoin, phenobarbital: Decrease lamotrigine levels, risking loss of efficacy.

Moderate Interactions (Monitor Closely): - Oral contraceptives: Reduce lamotrigine clearance, potentially raising concentrations. - Serotonergic agents (e.g., SSRIs, SNRIs): May increase risk of serotonin syndrome. - Other enzyme‑inducing antiepileptics: May necessitate dose adjustments.